Methotrexate and psoriasis: Consensus conference - 14/03/12
Funding sources: None. |
|
Disclosure: Dr Kalb has served as an investigator for Abbott, Amgen, Astellas, and Centocor; a consultant for Abbott, Amgen, Jannsen, LEO Pharmaceuticals, and Stiefel; and received lecture fees from Abbott, Amgen, Jannsen, Galderma, and Stiefel. Dr Strober has been a consultant, investigator, and served on the advisory boards for Amgen, Abbott, Jannsen, Celgene, Pfizer, and Novartis and received lecture fees from Abbott. Dr Weinstein declared no conflicts of interest. Dr Lebwohl has served as a consultant for AbGenomics, Allos, Amgen, Can-Fite BioPharma, DermaGenoma, DermiPsor, Glenmark Pharmaceuticals, Helix BioMedix, Jannsen, LEO Pharmaceuticals, Novartis, Pfizer, Ranbaxy, Stiefel, and Valeant; and served as an investigator for Clinuvel, Celgene, LEO Pharmaceuticals, Can-Fite BioPharma, and Jannsen. |
Vol 66 - N° 4
P. 689-690 - avril 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?